NCT05070039
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Maisa Hashem Mohammed Sohag, Egypt
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
417 public trials
125 recruiting studies
Carcinoma, Transitional Cell trial results
NCT01780545
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
- Locations
-
- University of Alabama Hematology Oncology Clinic at Medical West Birmingham, Alabama, United States
- City of Hope: Duarte Duarte, California, United States
- City of Hope: Antelope Valley Lancaster, California, United States
- USC: Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT01524991
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- City of Hope: Duarte Duarte, California, United States
- IU Health Goshen Hospital Goshen, Indiana, United States
- Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States
- IU Health Central Indiana Cancer Centers Indianapolis, Indiana, United States
NCT03945084
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Azienda Sanitaria Locale CN2 - Alba e Bra Alba, Italy
- Azienda USL Toscana Sud Est, Ospedale San Donato Arezzo, Italy
- Istituto Tumori Giovanni Paolo II - IRCCS Bari, Italy
- Presidio Ospedaliero Senatore A.Perrino Brindisi, Italy
Completed
Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine
NCT03633110
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
- University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT03071328
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
- Locations
-
- Duke University Medical Center Durham, North Carolina, United States
NCT04125693
- Conditions
- Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +31 more
- Locations
-
- Kantonsspital St. Gallen Sankt Gallen, Canton of St. Gallen, Switzerland
NCT01772004
- Conditions
- Adenocarcinoma, Adnexal Diseases, Adrenal Cortex Diseases, +62 more
- Locations
-
- Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States
- Scottsdale Healthcare Corporation Scottsdale, Arizona, United States
- Pinnacle Oncology Hematology Scottsdale, Arizona, United States
- Highlands Oncology Group Rogers, Arkansas, United States
NCT02573259
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Melanoma, +21 more
- Locations
-
- Clinical Research Unit Los Angeles, California, United States
- Ronald Reagan Medical Center, Department of Radiological Sciences Los Angeles, California, United States
- Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
- UCLA Hematology & Oncology Clinic Los Angeles, California, United States
Completed
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
NCT03520231
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +20 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada